Enzo Biochem (ENZ) Reports Q4 EPS of $0.77
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q4 EPS of $0.77, versus $0.18 reported last year. Revenue for the quarter came in at $26.6 million, versus $25.7 million reported last year.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Noble Capital Starts Xerox (XRX) at Outperform
- Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
